In type 2 diabetes mellitus, hyperinsulinemia and elevated insulin-like growth factor 1 (IGF-1) levels drive activation of the PI3K/Akt/mTOR pathway, enhancing cell survival and proliferation [57]. The gene discussed is IGF1; the disease is hyperinsulinism.